Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
1,500.00
+60.00 (4.17%)
At close: Jul 31, 2026
Kyung Nam Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 29,429 | 62,596 | 59,868 | 82,676 | 88,518 | 140,585 | |
Market Cap Growth | -40.79% | 4.56% | -27.59% | -6.60% | -37.04% | -17.15% |
Enterprise Value | 30,340 | 69,553 | 82,641 | 73,133 | 109,068 | 157,440 |
Last Close Price | 1500.00 | 4005.00 | 6728.67 | 10721.07 | 15611.41 | 28500.11 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 3.06 | 6.21 | - | - | - | - |
Forward PE | - | 12.72 | 12.72 | 12.72 | 12.72 | 12.72 |
PS Ratio | 0.52 | 1.03 | 1.01 | 1.40 | 1.37 | 1.98 |
PB Ratio | 0.26 | 0.54 | 0.67 | 0.88 | 1.22 | 2.45 |
P/TBV Ratio | 0.26 | 0.55 | 0.86 | 0.89 | 1.24 | 2.48 |
P/OCF Ratio | 48.98 | 34.05 | 86.35 | 1155.05 | - | 53.76 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 0.54 | 1.14 | 1.39 | 1.24 | 1.69 | 2.22 |
EV/EBITDA Ratio | 11.15 | 31.16 | - | - | - | 38.38 |
EV/EBIT Ratio | 45.61 | - | - | - | - | 61.11 |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.32 | 0.33 | 0.57 | 0.35 | 0.55 | 0.72 |
Debt / EBITDA Ratio | 13.37 | 16.84 | - | - | - | 10.09 |
Net Debt / Equity Ratio | -0.08 | -0.11 | 0.18 | -0.13 | 0.22 | 0.24 |
Net Debt / EBITDA Ratio | -3.26 | -5.93 | -22.07 | 8.47 | -2.35 | 3.39 |
Net Debt / FCF Ratio | 1.33 | 2.84 | -1.01 | 4.42 | -1.40 | -0.32 |
Asset Turnover | 0.35 | 0.37 | 0.39 | 0.45 | 0.51 | 0.71 |
Inventory Turnover | 3.11 | 3.39 | 3.07 | 3.21 | 3.69 | 4.39 |
Quick Ratio | 1.43 | 1.41 | 0.81 | 1.35 | 1.56 | 1.22 |
Current Ratio | 1.76 | 1.68 | 1.03 | 1.70 | 2.16 | 1.49 |
Return on Equity (ROE) | -3.29% | -3.98% | -10.42% | -9.41% | -4.94% | -8.66% |
Return on Assets (ROA) | 0.24% | -0.09% | -1.47% | -1.62% | -4.34% | 1.60% |
Return on Invested Capital (ROIC) | 0.59% | -0.23% | -3.84% | -4.01% | -10.94% | 4.70% |
Return on Capital Employed (ROCE) | 0.50% | -0.20% | -3.60% | -3.60% | -8.80% | 2.90% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Earnings Yield | 32.65% | 16.10% | -35.07% | -9.47% | -3.86% | -3.90% |
FCF Yield | -22.31% | -7.43% | -26.94% | -3.36% | -13.16% | -30.56% |
Buyback Yield / Dilution | -260.02% | -22.60% | -21.50% | -27.71% | -32.46% | -11.06% |